Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Transition Therapeutics Inc (NASDAQ:TTHI)

1.62
Delayed Data
As of Jul 22
 +0.03 / +1.89%
Today’s Change
0.66
Today|||52-Week Range
2.75
-15.62%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close1.59
Today’s open1.56
Day’s range1.56 - 1.64
Volume187,369
Average volume (3 months)86,989
Market cap$63.0M
Dividend yield--
Data as of 3:47pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-78.76%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.14

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...+0.08+2.61%
TRILTrillium Therapeutic...-0.06-0.66%
GALTGalectin Therapeutic...+0.02+1.35%
CGIXCancer Genetics Inc0.000.00%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateSeptember 13, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$43.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
President &
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts

Partner Offers

Search for Jobs